Home About Us Research & Development Investors & Media Careers Contact Us

News Highlights

August 21, 2014
Concert Pharmaceuticals to Present at Robert W. Baird 2014 Healthcare Conference on September 4, 2014

August 12, 2014
Concert Pharmaceuticals Reports Second Quarter 2014 Financial Results and Provides Company Update; Conference Call Scheduled Today at 8:30 a.m. EDT, Including Discussion of Positive Results from Phase 1 Brain Imaging Trial of CTP-354

July 21, 2014
Jazz Pharmaceuticals and Concert Pharmaceuticals Provide a Phase 1 Clinical Trial Update on JZP-386



Welcome to Concert

Concert Pharmaceuticals is a clinical stage biopharmaceutical company. We apply our extensive knowledge of deuterium chemistry to discover and develop novel small molecule drugs.

MedChem News
Deuterium Medicinal Chemistry: A New Approach to Drug Discovery and Development Read more

Issued U.S. Patents

Concert is building a broad patent estate. View List


Concert has presented at a number scientific meetings. View Poster presentations

  ©2009 Concert Pharmaceuticals, Inc.
Design by Digizyme
Home     Sitemap